Javascript must be enabled to continue!
Global scientific research progress in mycetoma: a bibliometric analysis
View through CrossRef
Abstract
Background
Mycetoma is a neglected tropical disease that attracts little attention in regard to research and publications and hence this study was undertaken to determine the trends and global scientific research output in mycetoma-related fields.
Methods
Mycetoma data were retrieved from the Web of Science (WoS) and Scopus databases. The MeSH Browser was used to extract relevant keywords. Biblioshiny software (R-studio cloud), VOSviewer v. 1.6.6 and SPSS software were used for data management.
Results
Research trends on mycetoma increased globally from 1999 to 2020. The results were 404 documents (4444 citations) in WoS and 513 documents (5709 citations) in Scopus, and the average number of citations per article was 11 in WoS and 11.13 in Scopus. There was a significant association between the total number of citations and the total citations per year in both WoS (r=0.833, p<0.0001) and Scopus (r=0.926, p<0.0001). Sudan, India, the Netherlands and Mexico were the top-ranking productive countries for mycetoma publications in WoS, while India, the USA and Mexico were the top-ranking countries in Scopus. Articles on mycetoma were mainly published in PLoS Neglected Tropical Diseases, the International Journal of Dermatology and the Journal of Clinical Microbiology. A. H. Fahal from the Mycetoma Research Centre, University of Khartoum, Sudan, had the highest number of citations in mycetoma research during 1999–2020, followed by W. W. J. van de Sande from the Erasmus Medical Centre, University of Rotterdam, the Netherlands, during 2003–2020.
Conclusion
The analysis provides insight into a global overview of Mycetoma research. In addition, the analysis holds a better understanding of the development trends that have emerged in Mycetoma over the past 21 years, which can also offer a scientific reference for future research.
Oxford University Press (OUP)
Title: Global scientific research progress in mycetoma: a bibliometric analysis
Description:
Abstract
Background
Mycetoma is a neglected tropical disease that attracts little attention in regard to research and publications and hence this study was undertaken to determine the trends and global scientific research output in mycetoma-related fields.
Methods
Mycetoma data were retrieved from the Web of Science (WoS) and Scopus databases.
The MeSH Browser was used to extract relevant keywords.
Biblioshiny software (R-studio cloud), VOSviewer v.
1.
6.
6 and SPSS software were used for data management.
Results
Research trends on mycetoma increased globally from 1999 to 2020.
The results were 404 documents (4444 citations) in WoS and 513 documents (5709 citations) in Scopus, and the average number of citations per article was 11 in WoS and 11.
13 in Scopus.
There was a significant association between the total number of citations and the total citations per year in both WoS (r=0.
833, p<0.
0001) and Scopus (r=0.
926, p<0.
0001).
Sudan, India, the Netherlands and Mexico were the top-ranking productive countries for mycetoma publications in WoS, while India, the USA and Mexico were the top-ranking countries in Scopus.
Articles on mycetoma were mainly published in PLoS Neglected Tropical Diseases, the International Journal of Dermatology and the Journal of Clinical Microbiology.
A.
H.
Fahal from the Mycetoma Research Centre, University of Khartoum, Sudan, had the highest number of citations in mycetoma research during 1999–2020, followed by W.
W.
J.
van de Sande from the Erasmus Medical Centre, University of Rotterdam, the Netherlands, during 2003–2020.
Conclusion
The analysis provides insight into a global overview of Mycetoma research.
In addition, the analysis holds a better understanding of the development trends that have emerged in Mycetoma over the past 21 years, which can also offer a scientific reference for future research.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Neurological Manifestations of Mycetoma
Neurological Manifestations of Mycetoma
Abstract
Introduction:
Mycetoma is a chronic specific granulomatous progressive and disfiguring subcutaneous inflammatory disease. It is caused by true fungi (Euomycetoma)...
Mycetoma of the hand
Mycetoma of the hand
OBJECTIVE: To describe the incidence and radiographic signs of hand infection in mycetoma. METHODS: A retrospective review was carried out from the radiographic records of 516 conf...
Neurological manifestations of mycetoma: a cross-sectional community-based study
Neurological manifestations of mycetoma: a cross-sectional community-based study
Introduction:
Mycetoma is a chronic specific granulomatous progressive and disfiguring subcutaneous inflammatory disease. It is caused by true fungi (Eumycetoma) or by ...
Bibliometric Analysis Bibliometric Analysis of Research (1980-2023)
Bibliometric Analysis Bibliometric Analysis of Research (1980-2023)
The concept of bibliometric analysis, in addition to seeing the developments in any scientific field over a certain period of time, also provides information about where the scient...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
CLINICAL, MICROBIOLOGICAL, AND HISTOPATHOLOGICAL EVALUATION OF MYCOSES AND MYCETOMA
CLINICAL, MICROBIOLOGICAL, AND HISTOPATHOLOGICAL EVALUATION OF MYCOSES AND MYCETOMA
Background:Subcutaneous mycoses and mycetoma are chronic granulomatous infections involving the skin and subcutaneous tissues, predominantly affecting individuals in tropical and s...

